The Registry of Toxic Effects of Chemical Substances
Phenol, 2,4 - dichloro - |
UPDATE: November 2004 | MW: 163.00 | MF: C6H4Cl2O |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
skin | rabbit
500 µL/24 hour
|
severe
|
NTIS** OTS0534822
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
ovary
|
1,400 µmol/L
|
MUREAV 400,169,1998
|
cytogenetic analysis
|
intraperitoneal | mouse
180 mg/kg
|
MUREAV 494,1,2001
|
DNA damage
|
rat
liver
|
200 µmol/L
|
EMMUEG 24,181,1994
|
DNA inhibition
|
hamster
ovary
|
1,200 µmol/L
|
MUREAV 400,169,1998
|
mutation in microorganisms
|
Salmonella typhimurium
|
333 µg/plate (-enzymatic activation step)
|
NTPTR* NTP-TR-353,1989
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
30 mg/L
|
NTPTR* NTP-TR-353,1989
|
morphological transform
|
mouse
fibroblast
|
20 mg/L/21 day (-enzymatic activation step)
|
EMMUEG 37,231,2001
|
sister chromatid exchange
|
hamster
ovary
|
3,100 µg/L
|
NTPTR* NTP-TR-353,1989
|
sex chromosome loss and nondisjunction
|
hamster
lung
|
500 µmol/L
|
MUREAV 182,135,1987
|
sperm morphology
|
intraperitoneal | mouse
180 mg/kg
|
MUREAV 494,1,2001
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 20 mg/kg (1-20 day pregnant)
|
Reproductive: Other developmental abnormalities
|
GISAAA 41(11),102,1976
|
oral | rat
lowest published toxic dose: 7,500 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
TOXID9 4,167,1984
|
oral | rat
lowest published toxic dose: 7,500 mg/kg (6-15 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
FAATDF 13,635,1989
|
oral | rat
lowest published toxic dose: 22 mg/kg (1-22 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Other developmental abnormalities
VCVGK* -,247,1994
|
oral | rat
lowest published toxic dose: 1,650 mg/kg (1-22 day pregnant)
|
Reproductive: Specific developmental abnormalities: Musculoskeletal system
|
VCVGK* -,247,1994
|
oral | rat
lowest published toxic dose: 22 mg/kg (1-22 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Other effects to embryo or fetus
GISAAA 40,102,1975
|
oral | rat
lowest published toxic dose: 3 mg/kg (multigenerations)
|
Reproductive: Effects on newborn: Physical | Reproductive: Effects on newborn: Other postnatal measures or effects
JTEHD6 14,723,1984
|
oral | rat
lowest published toxic dose: 7,500 mg/kg (6-15 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Effects on embryo or fetus: Fetal death Reproductive: Other effects to embryo or fetus
FAATDF 13,635,1989
|
subcutaneous | mouse
lowest published toxic dose: 666 mg/kg (6-14 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | Reproductive: Specific developmental abnormalities: Musculoskeletal system
NTIS** PB223-160
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
skin | mouse
lowest published toxic dose: 16 gm/kg/39 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Skin and Appendages: Tumors
CNREA8 19,413,1959
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lethal dose (50 percent kill): 153 mg/kg
|
N/R
|
JMCMAR 18,868,1975
|
intraperitoneal | rat
lethal dose (50 percent kill): 430 mg/kg
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold Nutritional and Gross Metabolic: Body temperature increase
BJPCAL 13,20,1958
|
intraperitoneal | rat
lethal dose (50 percent kill): 430 mg/kg
|
N/R
|
VCVGK* -,245,1994
|
oral | guinea pig
lowest published lethal dose: 2 gm/kg
|
N/R
|
ABANAE 7,321,1959/1960
|
oral | mammal (species unspecified)
lethal dose (50 percent kill): 464 mg/kg
|
N/R
|
GISAAA 45(10),16,1980
|
oral | mouse
lethal dose (50 percent kill): 1,276 mg/kg
|
Behavioral: Altered sleep time (including change in righting reflex) | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea
FAATDF 5,478,1985
|
oral | mouse
lethal dose (50 percent kill): 1,276 mg/kg
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold
TOLED5 29,39,1985
|
oral | mouse
lethal dose (50 percent kill): 580 mg/kg
|
N/R
|
BFUUA* 31,1,1989
|
oral | rat
lethal dose (50 percent kill): 47 mg/kg
|
Behavioral: Food intake (animal) | Lung, Thorax, or Respiration: Dyspnea Gastrointestinal: Other changes
NTIS** OTS0534822
|
oral | rat
lethal dose (50 percent kill): 380 mg/kg
|
N/R
|
VCVGK* -,245,1994
|
subcutaneous | rat
lethal dose (50 percent kill): 580 mg/kg
|
N/R
|
BFUUA* 31,1,1989
|
skin | mammal (species unspecified)
lethal dose (50 percent kill): 790 mg/kg
|
N/R
|
GISAAA 45(10),16,1980
|
skin | rabbit
lowest published lethal dose: 3,160 mg/kg
|
Behavioral: Food intake (animal) | Lung, Thorax, or Respiration: Pulmonary emboli Liver: Other changes
NTIS** OTS0534822
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | rat
lowest published toxic concentration: 100 mg/m3/4 hour/152 day- intermittent
|
Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi | Liver: Liver function tests impaired
VCVGK* -,247,1994
|
intramuscular | mouse
lowest published toxic dose: 40,320 mg/kg/24 week- continuous
|
Liver: Other changes | Liver: Changes in liver weight
TOIZAG 19,356,1972
|
intramuscular | rat
lowest published toxic dose: 7,500 mg/kg/10 day- intermittent
|
Lung, Thorax, or Respiration: Other changes | Skin and Appendages: Other: Hair Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
FAATDF 13,635,1989
|
intramuscular | rat
lowest published toxic dose: 2,000 mg/kg/10 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
FAATDF 13,635,1989
|
intraperitoneal | guinea pig
lowest published toxic dose: 480 mg/kg/2 week- intermittent
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Lipids including transport
INHEAO 34,415,1996
|
oral | guinea pig
lowest published toxic dose: 106.5 mg/kg/213 day- intermittent
|
Liver: Changes in liver weight | Endocrine: Changes in spleen weight Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase
VCVGK* -,247,1994
|
oral | mouse
lowest published toxic dose: 31,770 mg/kg/90 day- continuous
|
Behavioral: Fluid intake | Blood: Changes in cell count (unspecified) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
FAATDF 5,478,1985
|
oral | mouse
lowest published toxic dose: 437 gm/kg/13 week- continuous
|
Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
NTPTR* NTP-TR-353,1989
|
oral | mouse
lowest published toxic dose: 67,200 mg/kg/14 day- continuous
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
NTPTR* NTP-TR-353,1989
|
oral | mouse
lowest published toxic dose: 591,220 mg/kg/103 week- continuous
|
Blood: Lymphoma including Hodgkin's disease | Tumorigenic: Active as anti-cancer agent
NTIS** PB90-106170/AS
|
oral | rat
lowest published toxic dose: 91 gm/kg/13 week- continuous
|
Blood: Changes in bone marrow not included in above
|
NTPTR* NTP-TR-353,1989
|
oral | rat
lowest published toxic dose: 7,500 mg/kg/10 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain | Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
BFUUA* 31,1,1989
|
oral | rat
lowest published toxic dose: 151,410 mg/kg/103 week- continuous
|
Blood: Leukemia | Tumorigenic: Active as anti-cancer agent
NTIS** PB90-106170/AS
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
International Agency for Research on Cancer (IARC) Cancer Review
|
Human Limited Evidence
|
IMEMDT 41,319,1986
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal No Evidence
|
IMEMDT 71,769,1999
|
TOXICOLOGY REVIEW
|
|
STEVA8 2,305,1974
|
TOXICOLOGY REVIEW
|
|
MUREAV 543,201,2003
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X4154; |
Number of Industries 1; Total Number of Facilities 6; Number of Occupations 1; Total Number of Employees Exposed 63; Total Number of Female Employees Exposed 23 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
ATSDR TOXICOLOGY PROFILE (NTIS** PB/93/110757/AS)
|
EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test
|
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used in synthesis of pesticides and pharmaceuticals
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9261
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NCI Carcinogenesis Studies (feed);no evidence:mouse,rat
|
|
REFERENCES:
CODEN
|
|
REFERENCE
ABANAE
|
Antibiotics Annual. (New York, NY) 1953-60. For publisher information, see AMACCQ.
|
BFUUA*
|
Beratergremium fuer umweltrelevante Altstoffe (BUA. Gesellschaft Deutscher Chemiker. Weinheim
; New York : VCH) 1992-
|
BJPCAL
|
British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For
publisher information, see BJPCBM.
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
FAATDF
|
Fundamental and Applied Toxicology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802)
V.1-40, 1981-97. For publisher information, see TOSCF2
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
INHEAO
|
Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki,
213 Japan) V.1- 1963-
|
JMCMAR
|
Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB
POB 57136, West End Stn., Washington, DC 20037) V.6- 1963-
|
JTEHD6
|
Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW,
Washington, DC 20005) V.1- 1975/76-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
NTIS**
|
National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse
for Scientific & Technical Information.
|
NTPTR*
|
National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709)
No.206-
|
STEVA8
|
Science of the Total Environment. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1972-
|
TOIZAG
|
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. (Toho Daigaku Igakkai,
21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143, Japan) V.1- 1954-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
VCVGK*
|
"Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia".
(Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia,
1994.
|
|